These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 30657916)

  • 1. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spread of artemisinin resistance in Plasmodium falciparum malaria.
    Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
    N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate
    Duffy S; Avery VM
    Microbiol Spectr; 2022 Oct; 10(5):e0128221. PubMed ID: 36094220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
    Fukuda N; Balikagala B; Ueno T; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Miida T; Mita T
    Clin Infect Dis; 2023 May; 76(9):1585-1593. PubMed ID: 36519341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates.
    Tirrell AR; Vendrely KM; Checkley LA; Davis SZ; McDew-White M; Cheeseman IH; Vaughan AM; Nosten FH; Anderson TJC; Ferdig MT
    Malar J; 2019 Aug; 18(1):295. PubMed ID: 31462253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.
    Das S; Manna S; Saha B; Hati AK; Roy S
    Clin Infect Dis; 2019 Sep; 69(7):1144-1152. PubMed ID: 30535043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.
    WWARN K13 Genotype-Phenotype Study Group
    BMC Med; 2019 Jan; 17(1):1. PubMed ID: 30651111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.
    Lo E; Nguyen J; Oo W; Hemming-Schroeder E; Zhou G; Yang Z; Cui L; Yan G
    BMC Infect Dis; 2016 Apr; 16():154. PubMed ID: 27084511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of Artemisinin-Resistant Malaria in Africa.
    Balikagala B; Fukuda N; Ikeda M; Katuro OT; Tachibana SI; Yamauchi M; Opio W; Emoto S; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Mita T
    N Engl J Med; 2021 Sep; 385(13):1163-1171. PubMed ID: 34551228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
    Wilairat P; Kümpornsin K; Chookajorn T
    Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.
    Birnbaum J; Scharf S; Schmidt S; Jonscher E; Hoeijmakers WAM; Flemming S; Toenhake CG; Schmitt M; Sabitzki R; Bergmann B; Fröhlke U; Mesén-Ramírez P; Blancke Soares A; Herrmann H; Bártfai R; Spielmann T
    Science; 2020 Jan; 367(6473):51-59. PubMed ID: 31896710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.
    Das S; Kar A; Manna S; Mandal S; Mandal S; Das S; Saha B; Hati AK
    Sci Rep; 2021 May; 11(1):9946. PubMed ID: 33976269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance.
    Grigg MJ; William T; Piera KA; Rajahram GS; Jelip J; Aziz A; Menon J; Marfurt J; Price RN; Auburn S; Barber BE; Yeo TW; Anstey NM
    Malar J; 2018 Dec; 17(1):463. PubMed ID: 30526613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.
    Kümpornsin K; Loesbanluechai D; de Cozar C; Kotanan N; Chotivanich K; White NJ; Wilairat P; Gomez-Lorenzo MG; Gamo FJ; Sanz LM; Lee MCS; Chookajorn T
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():186-190. PubMed ID: 34673330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.
    Uwimana A; Umulisa N; Venkatesan M; Svigel SS; Zhou Z; Munyaneza T; Habimana RM; Rucogoza A; Moriarty LF; Sandford R; Piercefield E; Goldman I; Ezema B; Talundzic E; Pacheco MA; Escalante AA; Ngamije D; Mangala JN; Kabera M; Munguti K; Murindahabi M; Brieger W; Musanabaganwa C; Mutesa L; Udhayakumar V; Mbituyumuremyi A; Halsey ES; Lucchi NW
    Lancet Infect Dis; 2021 Aug; 21(8):1120-1128. PubMed ID: 33864801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.